Literature DB >> 311979

[Exocrine pancreatic function test by N-benzoyl-L-tyrosyl-p-aminobenzoic acid (author's transl)].

R Thienhaus, C Niederau.   

Abstract

Urinary excretion of p-aminobenzoic acid (PABA) within 6 h after oral administration of N-benzoyl-L-tyrosyl-P-aminobenzoic acid (Peptide-PABA) was measured. In healthy subjects PABA-excretion rate was not different after 150 mg and 1 g Peptide-PABA. PABA-recovery was significantly lower in patients with chronic pancreatitis. Seperation between healthy persons and patients with chronic pancreatic insufficiency was better with 1 g Peptide-PABA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311979

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  4 in total

1.  In vitro and in vivo analysis of the PABA test compared with the Lundh test--influence of intraluminal pH.

Authors:  F J Hoek; G T Sanders; A Teunen; G N Tijtgat
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

Review 2.  Exocrine pancreatic function tests.

Authors:  P G Lankisch
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

3.  Value of serum PABA as a pancreatic function test.

Authors:  C Lang; K Gyr; I Tonko; D Conen; G A Stalder
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

4.  Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.

Authors:  V S Hubbard; R O Wolf; L A Lester; A C Egge
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.